HOME >> MEDICINE >> NEWS
No-hands origami: New DNA self-assembly makes more complex structures, more easily

ATLANTA A computer scientist at CalTech has developed a way to "program" strands of DNA to fold themselves into a variety of complex shapes an accomplishment considered the most intricate yet in the field of self-assembly and via a method he calls so simple that "a high schooler could do it." The potential implications of the work are enormous, not only in the area of electronic miniaturization but even in such a diverse application as organizing and automating an assembly line for protein manufacturing.

Paul Rothemund, Ph.D., of the California Institute of Technology in Pasadena, Calif., will present his findings March 26 in Atlanta, Ga., at the 231st national meeting of the American Chemical Society, the worlds largest scientific society. A paper on the discovery, which Rothemund calls "scaffolded DNA origami," was published in the March 16 issue of the journal Nature.

The complexity of shapes that Rothemund has achieved from programming strands of DNA, including snowflakes, smiley faces and even a map of the Americas, are about 10-fold more complex than the field of molecular self-assembly has mustered to date, yet one doesnt even need a science degree to make them, according to Rothemund.

The technique is simple because it starts with a single, complete scaffold one strand of viral DNA and uses short, complementary strands as staples to fold and keep the scaffold in place.

In Rothemunds one-pot approach, "the scaffold is already perfect; all the information is there," he says, "so you can afford to be sloppy about the purity and quantities of the staples. All that matters is that some good copies of them are in there somewhere."

Folding DNA into smiley faces would be little more than fancywork if it werent for its implications. Computer experts, for example, believe the traditional silicon chip has about a decades worth of technology left to squeeze before miniaturization leaves it behind. What will comprise th
'"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
20-Mar-2006


Page: 1 2

Related medicine news :

1. PneuStep -- MRI-safe motor makes robotic biopsies possible
2. Governments reliance on free market economics makes essential drug prices too high for the poor
3. Hormone drug type makes survival difference in advanced breast cancer
4. A spoonful of sugar makes the medicine go to work
5. Bottleneck in blood supply makes brain vulnerable to strokes
6. Nap a day makes doctors OK, Stanford study finds
7. Domino transplant program makes best use of altruistic donated kidneys
8. For men, catheter type makes a huge difference in urinary infection risk, study finds
9. Coffee makes us more likely to say yes
10. New model makes diagnosing osteoporosis easier
11. Hysterectomy type makes little difference in later sexual function

Post Your Comments:
(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... the body,s system for repairing damage to the genetic ... as it may seem, those compounds are sparking optimism ... by a mutation in BRCA, a gene that made ... mutation. The compounds, termed PARP inhibitors, are the topic ... Chemical & Engineering News . C&EN is the ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Alternatives, ... permits some patients to quit using drugs while allowing ... Adi Jaffe, the founders of Alternatives, believe that abstinence-only ... before they enter treatment and that this approach hurts ... million people in the United States need treatment for ...
(Date:6/19/2013)... 2013 Many trying-to-conceive couples seek ... necessary, according to a recent study ... The results of this research confirm what Fairhaven ... decade – that trying-to-conceive women would benefit from ... body weight. Fairhaven Health is a leading provider ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance for ... fatigue. The need to urgently address this issue ... Sentinel Event Alert #50 , "Medical device alarm safety in ... between January 2008 and June 2012, there were 98 alarm ... in death (82%) , 13 resulted in permanent loss ...
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... 2013   Nektar Therapeutics (Nasdaq: NKTR ... liability (HAL) study for NKTR-181, a first-in-class, opioid ... brain.  This slow rate of entry is designed to reduce ... addiction to current opioid analgesics. 1 In the study ... to placebo in "drug liking" and "feeling high" scores and ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
Cached News: